Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474382 · ClinicalTrials.gov registry record · Phase 4
Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients
A Phase 4 study of Anesthesia, Local and Dental Anesthesia, sponsored by Novocol Pharmaceutical of Canada.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 7
- Study locations
NCT01474382: Completed Phase 4 study of Anesthesia, Local and Dental Anesthesia, sponsored by Novocol Pharmaceutical of Canada.
NCT01474382 is a Phase 4 study of Anesthesia, Local and Dental Anesthesia that has completed, run by Novocol Pharmaceutical of Canada. The registered enrollment target is 150 participants, above the 75-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (100% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01474382, a Phase 4 study of Anesthesia, Local and Dental Anesthesia, has completed, sponsored by Novocol Pharmaceutical of Canada.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this study is to determine whether OraVerse is safe and effective for the reversal of dental anesthesia in children 2 to 5 years of age weighing at least 10 kg.
Conditions Studied
Interventions
- OTHER Sham injection
- DRUG OraVerse
Study Locations (7)
Pennsylvania
- University of Pennsylvania School of Dental - Philadelphia
- University of Pittsburgh School of Dental Medicine - Pittsburgh
California
- University of California, San Francisco - San Francisco
Indiana
- Indiana University School of Dentistry - Indianapolis
Ohio
- Nationwide Children's Hospital - Columbus
Utah
- Jean Brown Research - Salt Lake City
Washington
- Center for Pediatric Dentistry - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
What the finished NCT01474382 record still lists
NCT01474382 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 75-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (100% higher).
The record links to 3 conditions, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which Sham injection is the first listed.
NCT01474382 lists 7 locations in 6 states (Pennsylvania, California, Indiana).
Frequently Asked Questions
What is clinical trial NCT01474382 about?
NCT01474382 is a clinical study titled "Study of OraVerse® for Safety and Efficacy in Pediatric Dental Patients". The purpose of this study is to determine whether OraVerse is safe and effective for the reversal of dental anesthesia in children 2 to 5 years of age weighing at least 10 kg.
What is the current status of trial NCT01474382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2012-02. Estimated completion is 2014-08.
What conditions does trial NCT01474382 study?
This clinical trial studies the following conditions: Anesthesia, Local, Dental Anesthesia, Anesthesia, Reversal.
What interventions are being tested in trial NCT01474382?
The interventions under investigation include: Sham injection (OTHER), OraVerse (DRUG).
Who is sponsoring clinical trial NCT01474382?
This trial is sponsored by Novocol Pharmaceutical of Canada, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01474382 being conducted?
This trial has 7 study locations across California, Indiana, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia, Local
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01474382's enrollment target sits among peer trials
150 3rd of 18 higher than 16 of 18 other Anesthesia, Local trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia, Local trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Split Face Study of the Duration of Local Anesthetics - Fourth Arm
RECRUITING · Phase 4
-
Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection
RECRUITING · Phase 4
-
Intralipid® 20% for Reversal of Local Anesthetics
ACTIVE NOT RECRUITING · Phase 4
-
Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years
COMPLETED · Phase 4
-
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
COMPLETED · Phase 4
-
Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia